Published on 22 Mar 2024 on Benzinga
Why Is Nkarta Stock Trading Lower On Friday? - Nkarta (NASDAQ:NKTX)
Thursday, in its fourth quarter 2023 earnings release, Nkarta Inc NKTX said it closed patient enrollment in its clinical trial of NKX101 and deprioritized the program as part of a pipeline realignment that directs primary resources to its lead pipeline program, NKX019, for autoimmune disease.
This follows a recent review of preliminary safety and response data from patients with r/r AML who received NKX101 after lymphodepletion (LD) comprising fludarabine and cytarabine (flu/Ara-C).